Cellectar biosciences stock split

The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Mar 17, 2020 Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. View today's stock price, news and analysis for Cellectar Biosciences Inc. (CLRB) . Barron's also provides information on historical stock ratings, target prices,  Cellectar Biosciences, Inc. (CLRB) Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. CLRB Split History Cellectar Biosciences (CLRB) has 2 splits in our CLRB split history database. The first split for CLRB took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRB owned pre-split, the shareholder now owned 1 share.

Split History. Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a  

Company profile for Cellectar Biosc (CLRB) including business summary, key statistics, ratios, sector. Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. Most Recent Split: The share split recorded and the date on which the split occurred. Cellectar Biosciences, Inc. (Form: 8-K, Received: 03/04 ... MADISON, WI (March 4, 2016) – Cellectar Biosciences, Inc. (NASDAQ: CLRB), an oncology-focused biotechnology company, today announces a 1-for-10 reverse stock split of its common stock, effective at the close of business today. Shares of Cellectar’s common stock will trade on a post-split basis beginning on March 7, 2016. Cellectar Biosciences Announces 1-for-20 Reverse Stock ...

Aug 15, 2014 Cellectar Biosciences, a Madison, WI-based startup developing a 1-for-20 reverse stock split to boost its stock price—and its chances of 

Cellectar Biosciences (CLRB) to Reverse Split Shares 1-for-10 Cellectar Biosciences, Inc. (NASDAQ: CLRB) announces a 1-for-10 reverse stock split of its common stock, effective at the close of business today. Shares of Cellectar’s common stock will trade CLRB Cellectar Biosciences, Inc. — Stock Price and ... Real-time trade and investing ideas on Cellectar Biosciences, Inc. CLRB from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Cellectar Biosciences Stock Forecast: up to 1260.690 USD ... Historical index on US Stock Market : D "Should I invest in Cellectar Biosciences stock?" "Should I trade "CLRB" stock today?" According to our live Forecast System, Cellectar Biosciences, Inc stock is an awesome long-term (1-year) investment*. "CLRB" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Cellectar Announces 1-for-10 Reverse Stock Split

Stock split history for Cellectar Biosciences since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see 

Stock Splits - The Online Investor Mar 13, 2020 · Direxion Shares Exchange Traded Fund Trust - Latin America Bull 3X Shares is an open-end manament investment company. The Fund seeks daily investment results, before fees and expenses that correspond to the S&P Latin America 40 Index. CLRB: Cellectar Biosciences Inc - Stock Price ... - CNBC

Get instant access to a free live streaming chart of the Cellectar Biosciences Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area

Cellectar Biosciences (NASDAQ:CLRB) will execute a 1:10 reverse split of its common stock effective after the close on Monday, July 16. Post-split trading will  

CLRB Split History Cellectar Biosciences (CLRB) has 2 splits in our CLRB split history database. The first split for CLRB took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRB owned pre-split, the shareholder now owned 1 share. Cellectar Announces 1-for-10 Reverse Stock Split ... Jul 13, 2018 · MADISON, Wis., July 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces a 1-for-10 reverse split of its common stock, effective at the close of business today.